What Gilead's 8-K filings say: 5 filings, latest Oct 29, 2026
Gilead filed its latest 8-K with the SEC on Oct 29, 2026. It discusses acquisition announced, bookings decline and capex increase.
Public (GILD)Biotechnology Research10,000+ employeesgilead.comLinkedIn
Get Gilead's live signals in Claude or ChatGPT, or by API
What changed at Gilead this week? Use Autobound signals for gilead.com.- Filed
- Oct 29, 2026
- Filings
- 5
- Signals
- 15
Source: Autobound Signal API · 68 signals tracked for Gilead · updated
8-K · latest 9
What Gilead's 8-K filings say
- SEC EDGAR
8-K
Filed · 5 signals
Gilead Enters Definitive Agreement to Acquire PepStar's Oral IL-23R Inhibitor Program
Gilead announced a definitive agreement to acquire the oral IL-23R inhibitor program from PepStar Therapeutics Limited, including lead asset HCXT-2001.
Gilead opens Research Center supporting $32 billion U.S. investment through 2030
Gilead announced the opening of a new Research Center to expand capabilities in oncology, inflammation, and research data science, marking the first of three projects in its $32 billion U.S.
$32B
investment in U.S. research, development and manufacturing through 2030
research data science
FDA Approves Bixlenvo Single-Tablet Regimen for HIV Treatment in Virologically Suppressed Adults
Gilead received U.S. FDA approval for Bixlenvo as a complete single-tablet regimen to replace current antiretroviral regimens.
Veklury sales drop 69% and Cell Therapy drops 18% in Q3 2026
Veklury sales decreased 69% to $86 million due to lower COVID-19 hospitalizations, while Cell Therapy sales dropped 18% to $355 million amid competitive headwinds.
$86M
Veklury sales in third quarter 2026
-69%
decrease in Veklury sales compared to same period in 2025
- SEC EDGAR
8-K
Filed · 3 signals
Gilead has secured $3 billion in new capital by issuing senior notes.
$3B
Total capital raised from senior notes offering to fund general corporate purposes, including potential acquisitions and strategic transactions.
Computershare Trust Company, National AssociationWells Fargo Bank, National AssociationBarclays Capital Inc.BofA Securities, Inc.
- SEC EDGAR
8-K
Filed · 1 signal
Gilead shareholders overwhelmingly affirm use of ESG/DEI metrics in executive compensation.
A stockholder proposal to report on the risks of using ESG/DEI metrics for executive pay was defeated by over 1 billion votes to 7 million.
Ernst & Young LLP
- SEC EDGAR
8-K
Filed · 3 signals
Gilead completes $7.1B acquisition of Arcellx, Inc. to bolster its cell therapy portfolio.
Gilead has spent approximately $7.1 billion to acquire Arcellx, Inc., making it a wholly owned subsidiary.
$7.1B
Total funds used to consummate the offer and merger for Arcellx, Inc.
Computershare, Inc.Computershare Trust Company, N.A.
- SEC EDGAR
8-K
Filed · 3 signals
Gilead announces definitive agreement to acquire Arcellx, Inc. for $115.00 per share.
Gilead is acquiring Arcellx, which will require significant post-merger integration of operations, technology, and personnel.
$260M
Termination fee payable by Arcellx to Gilead under specified circumstances of the merger agreement.
Gilead's acquisition of Arcellx will necessitate the integration of all business functions, including R&D, finance, HR, and IT systems.
$260M
Termination fee payable by Arcellx under certain conditions, indicating the high financial stakes and commitment to the transaction.
Showing 9 of 15 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Gilead with the Signal API
One POST /v1/companies/enrich call with gilead.com returns Gilead 8-K signals (sec-8k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"gilead.com","signal_types":["sec-8k"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 8-K Filings records, as a CSV.
Same industry
8-K at related companies
Questions about Gilead 8-K
When did Gilead file its latest 8-K?
What did Gilead disclose in its latest 8-K?
Where can I read Gilead's 8-K filing?
Page updated , the date of the newest row on this page.
Source. Current reports (Form 8-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .